• 1
    Roy Chowdhury J, Grossman M, Gupta S, Roy Chowdhury N, Baker JR, Wilson JM. Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDL receptor deficient rabbits. Science 1991; 254: 18021805.
  • 2
    Grossman M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Muller D, Lupien PJ. et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia. Nat Genet 1994; 6: 335341.
  • 3
    Gupta S. Hepatocyte transplantation: new strategies for hepatic reconstitution and gene therapy. Indian J Gastroenterol 1994; 13: 1323.
  • 4
    Gupta S, Roy Chowdhury J. Hepatocyte transplantation. In: AriasIM, BoyerJ, FaustoN, et al., eds. The liver: biology and pathobiology. Ed 3. New York: Raven 1994: 15191536.
  • 5
    Gupta S, Chowdhury NR, Jagtiani R, Gustin K, Shafritz DA, Chowdhury JR, Burk RD. A novel system for transplantation of isolated hepatocytes utilizing HBsAg producing transgenic donor cells. Transplantation 1990; 50: 472475.
  • 6
    Gupta S, Aragona E, Vemuru RP, Bhargava K, Burk RD, Chowdhury JR. Permanent engraftment and function of hepatocytes delivered to the liver: implications for gene therapy and liver repopulation. Hepatology 1991; 14: 144149.
  • 7
    Ponder KP, Gupta S, Leland F, Darlington G, Finegold M, De-Mayo J, Ledley FD. et al. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci U S A 1991; 88: 12171221.
  • 8
    Rhim JA, Sandgren EP, Degen JL, Palmiter RD, Brinster RL. Replacement of diseased mouse liver by hepatic cell transplantation. Science 1994; 263: 11491152.
  • 9
    Vemuru RP, Davidson A, Aragona E, Burk RD, Chowdhury JR, Gupta S. Immune tolerance to a defined heterologous antigen following intrasplenic hepatocyte transplantation: implications for human gene therapy. FASEB J 1992; 6: 28362842.
  • 10
    Gupta S, Vemuru RP, Lee C-D, Yemeni P, Aragona E, Burk RD. Hepatocytes exhibit superior transgene expression after transplantation into liver and spleen compared with peritoneal cavity or dorsal fat pad: implications for hepatic gene therapy. Human Gene Ther 1994; 5: 959967.
  • 11
    Gupta S, Yemeni P, Vemuru RP, Lee CD, Yellin EL, Bhargava KK Studies on the safety of intrasplenic hepatocyte transplantation: relevance to ex-vivo gene therapy and liver repopulation in acute hepatic failure. Human Gene Ther 1993; 4: 249257.
  • 12
    Gupta S, Lee C-D, Vemuru RP, Bhargava KK. 111lndium-labeling of hepatocytes for analyzing biodistribution of transplanted cells. Hepatology 1994; 19: 750757.
  • 13
    Gupta S, Rajvanshi P, Lee C-D. Integration of transplanted hepatocytes in host liver plates demonstrated with dipeptidyl pep-tidase IV deficient rats. Proc Natl Acad Sci U S A 1995 92: 58605864.
  • 14
    Xu X, Schwab AJ, Barker F III, Goresky CA, Pang KS. Salicylamide sulfate cell entry in perfused rat liver: a multiple-indicator dilution study. Hepatology 1994; 19: 229244.
  • 15
    Laishes BA, Williams GM. Conditions affecting primary cell cultures of functional adult rat hepatocytes. 1. The effect of insulin. In Vitro 1976; 12: 521532.
  • 16
    Soriano HE, Lewis D, Legner M, Brandt M, Baley P, Darlington G, Finegold M. et al. Use of Dil marked hepatocytes to demonstrate orthotopic, intrahepatic engraftment following hepatocellular transplantation. Transplantation 1992; 54: 717723.
  • 17
    Fujioka H, Hunt PJ, Rozga J, Wu GD, Cramer DV, Demetriou AA, Moscioni AD. Carboxyfluorescein (CFSE) labeling of hepatocytes for short-term localization following intraportal transplantation. Cell Transplantation 1994; 3: 397408.
  • 18
    Thompson NL, Hixson DC, Callanan H, Panzica M, Flanagan D, Faris RA, Hong W. et al. A Fischer rat substrain deficient in dipeptidyl peptidase IV activity makes normal steady-state RNA levels and an altered protein. Biochem J 1991; 273: 497502.
  • 19
    Tsuji E, Misumi Y, Fujiwara T, Takami N, Ogata S, Ikehara Y. An active-site mutation (Gly633 [RIGHTWARDS ARROW] Arg) of dipeptidyl peptidase IV causes its retention and rapid degradation in the endoplasmic reticulum. Biochemistry 1992; 31: 1192111927.
  • 20
    Watanabe Y, Kojima-Komatsu T, Iwaki-Egawa S, Fujimoto Y. Increased excretion of proline-containing peptides in dipeptidyl peptidase IV-deficient rats. Res Comm Chem Pathol Pharmacol 1993; 81: 323330.
  • 21
    Hegen M, Camerini D, Fleischer B. Function of dipeptidyl peptidase IV (CD26, TplOS) in transfected human T cells. Cell Immunol 1993; 146: 249260.
  • 22
    Fukui Y, Yamamoto A, Kyoden T, Kato K, Tashiro Y. Quantitative immunogold localization of dipeptidyl peptidase IV (DPPIV) in rat liver cells. Cell Struct Funct 1990; 15: 117125.
  • 23
    Nagase S, Shimamune K, Shimuya S. Albumin-deficient rat mutant. Science 1979; 205: 590591.
  • 24
    Shalaby F, Shafritz DA. Exon skipping during splicing of albumin mRNA precursors in Nagase analbuminemic rats. Proc Natl Acad Sci U S A 1990; 87: 26522656.
  • 25
    Demetriou AA, Whiting JF, Feldman D, Levenson SM, Roy Chowdhury N, Moscioni AD, Kram M. et al. Replacement of liver function in rat by transplantation of microcarrier-attached hepatocytes. Science 1986; 233: 11901192.
  • 26
    Chojkier M, Groszmann RJ. Measurement of portal-systemic shunting in the rat by using γ-labeled microspheres. Am J Physiol 1981; 240: G371G375.
  • 27
    Knowles BB, Howe CC, Aden DP. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science 1980; 209: 497499.
  • 28
    Price J, Turner D, Cepko C. Lineage analysis in the vertebrate nervous system by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A 1987; 84: 156160.
  • 29
    Kerr A, Rajvanshi P, Gupta S. Transcatheter hepatocyte transplantation: Preclinical studies of anatomic consequences in the portal venous system. Academ Radiol 1994; 1: 229236.
  • 30
    Lojda Z. Studies on dipeptidyl(amino)peptidase IV (Glycylpro-line naphthylamidase). Histochemistry 1979; 59: 153166.
  • 31
    Wachstein M, Meisel E. Histochemistry of hepatic phosphatases at a physiologic pH. Am J Clin Pathol 1955; 27: 1323.
  • 32
    Teutsch HF. Improved method for the histochemical demonstration of glucose-6-phosphatase activity. Histochemistry 1978; 57: 107117.
  • 33
    Darby H, Gupta S, Johnstone R, Selden AC, Hodgson HJF. Observations on rat spleen reticulum during the development of syngeneic hepatocellular implants. Br J Exp Path 1986; 67: 329339.
  • 34
    Vemuru RP, Aragona E, Hurston E, Chowdhury JR, Shafritz DA, Gupta S. Liver cell-type dependent expression in vivo of an introduced bacterial β-galactosidase gene [Abstract]. Hepatology 1991; 14: 111A.
  • 35
    Coleman WB, Wennerberg AE, Smith GJ, Grisham JW. Regulation of the differentiation of diploid and some aneuploid rat liver epithelial (stemlike) cells by the hepatic microenvironment. Amer J Pathol 1993; 142: 13731382.
  • 36
    Aragona E, Gupta S, Shafritz DA, Burk RD. Hepatitis B virus surface antigen (HBsAg) mRNA is differentially expressed in epithelial cells of transgenic mice [Abstract]. Hepatology 1990; 12: 875.
  • 37
    Vroemen JP, Buurman WA, Schutte B, Maessen JG, van der Linden CJ, Kootstra G. The cytokinetic behavior of donor hepatocytes after syngeneic hepatocyte transplantation into the spleen. Transplantation 1988; 45: 600607.
  • 38
    Maganto P, Traber PG, Rusnell C, Dobbins WO III, Keren D, Gumucio JJ. Long-term maintenance of the adult pattern of liver-specific expression for P-450b, P-450e, albumin and α-fetoprotein genes in intrasplenically transplanted hepatocytes. Hepatology 1990; 11: 585592.
  • 39
    Wilson JM, Roy Chowdhury N, Grossman M, Gupta S, Jeffers J, Huang T-J, Roy Chowdhury J. Transplantation of allogeneic hepatocytes into LDL receptor deficient rabbits leads to transient improvement in hypercholesterolemia. Clin Biotechnol 1991; 3: 2126.
  • 40
    Mito M, Kusano M, Kauwara Y. Hepatocyte transplantation in man. Transp Proc 1992; 24: 30523053.
  • 41
    Ribiero J, Nordlinger B, Ballet F, Cynober L, Coudray-Lucas C, Baudromont M, Legendre C. et al. Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval shunted rats. Hepatology 1992; 15: 1218.
  • 42
    Hamaguchi H, Yamaguchi Y, Goto M, Misumi M, Hisama N, Miyanari N, Mori K. et al. Hepatic biliary transport after hepatocyte transplantation in Eizai hyperbilirubinemic rats. Hepatology 1994; 20: 220224.
  • 43
    Onodera K, Kasai S, Kato K, Sawa M, Mito M, Nozawa M. Effects of intrasplenic hepatocyte transplantation in rats congenitally deficient in ascorbic acid biosynthetic enzyme. Cell Transplant 1994; 3: S31S34.
  • 44
    Rozga J, Holzman M, Moscioni AD, Fujiko H, Morsiani E, Demetriou AA. Repeated intraportal hepatocyte transplantation in analbuminemic rats. Cell Transplant 1995; 4: 237243.
  • 45
    Selden AC, Gupta S, Johnstone R, Hodgson HJF. The pulmonary vascular bed as a site for implantation of isolated liver cells in inbred rats. Transplantation 1984; 38: 8183.
  • 46
    Sandbichler P, Erhart R, Herbst P, Vogel W, Herold M, Dietze O, Schmid Th. et al. Hepatocellular transplantation into the lung in chronic liver failure following bile duct obstruction in the rat. Cell Transplant 1994; 5: 409412.
  • 47
    Sigal S, Rajvanshi P, Reid LM, Gupta S. Demonstration of differentiation in hepatocyte progenitor cells using dipeptidyl peptidase IV deficient mutant rats. Cell Mol Biol Res 1995; 41: 3947.
  • 48
    Fausto N. Liver stem cells. In: AriasIM, BoyerJ, FaustoN. et al., eds. The liver: biology and pathobiology. 3rd Edition. New York: Raven, 1994: 15011518.
  • 49
    Vemuru RP, Aragona E, Gupta S. Analysis of hepatocellular proliferation: study of archival liver tissue is facilitated by endogenous genetic markers of DNA replication. Hepatology 1992; 16: 968973.